Abstract
Background
The risk for occult neck nodal metastasis in carcinoma of the parotid gland is inconclusive. Therefore, addressing a negative neck prophylactically and the extent to do so remain controversial. This systematic review aimed to determine the rate of occult nodal metastasis for each neck level, and consequently, to elucidate the proper extent of elective neck dissection (END).
Methods
A meta-analysis of all studies that included patients with a diagnosis of parotid malignancies who underwent an END was performed. The risk for occult nodal metastasis was calculated for each neck level separately.
Results
The search strategy identified 124 papers from January 1980 to December 2019 in the various databases. Nine retrospective studies (n =548) met the inclusion criteria. The risk for occult neck nodal metastasis ranged from 0.0 to 9.43% with a random-effect model of 2.2% for level 1 (n =459), from 3.4 to 28.38% with a random-effect model of 16.51% for level 2 (n =548), from 0.0 to 21.63% with a random-effect model of 4.23% for level 3 (n =518), from 0.0 to 17.02% with a fixed-effect model of 0.39% for level 4 (n =310), and from 0.0 to 11.63% with a fixed-effect model of 1.7% for level 5 (n =417).
Conclusion
The rate of occult neck nodal metastasis in parotid malignancies is low, with neck level 2 the most commonly involved. The results of this meta-analysis prevented the authors from substantiating the appropriate extent of an END in parotid cancer.
Similar content being viewed by others
References
Nobis C-P, Rohleder NH, Wolff K-D, Wagenpfeil S, Scherer EQ, Kesting MR. Head and neck salivary gland carcinomas: elective neck dissection, yes or no? J Oral Maxillofac Surg. 2014;72:205–210.
Gould EA, Winship T, Philbin PH, Kerr HH. Observations on a “sentinel node” in cancer of the parotid. Cancer. 1960;13:77–8.
Armstrong JG, Harrison LB, Spiro RH, Fass DE, Strong EW, Fuks ZY. Malignant tumors of major salivary gland origin: a matched-pair analysis of the role of combined surgery and postoperative radiotherapy. Arch Otolaryngol Head Neck Surg. 1990;116:290–3.
Kim BY, Hyeon J, Ryu G, et al. Diagnostic accuracy of fine-needle aspiration cytology for high-grade salivary gland tumors. Ann Surg Oncol. 2013;20:2380–7.
Vartanian JG, Gonçalves Filho J, Kowalski LP, et al. An evidence-based analysis of the management of N0 neck in patients with cancer of the parotid gland. Expert Rev Anticancer Ther. 2019;19:899–908.
Holsinger FC, Bui DT. Anatomy, function, and evaluation of the salivary glands. Salivary Gland Disorders: Springer; 2007:1–16.
Yoo SH, Roh JL, Kim SO, et al. Patterns and treatment of neck metastases in patients with salivary gland cancers. J Surg Oncol. 2015;111:1000–6.
Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systemat Rev. 2015;4:1.
Spitz MR, Batsakis JG. Major salivary gland carcinoma: descriptive epidemiology and survival of 498 patients. Arch Otolaryngol. 1984;110:45–9.
Medina JE. Neck dissection in the treatment of cancer of major salivary glands. Otolaryngol Clin North Am. 1998;31:815–22.
de Brito Santos IR, Kowalski LP, de Araujo VC, Logullo AF, Magrin J. Multivariate analysis of risk factors for neck metastases in surgically treated parotid carcinomas. Arch Otolaryngol Head Neck Surg. 2001;127:56–60.
Zbären P, Schär C, Hotz MA, Loosli H. Value of fine-needle aspiration cytology of parotid gland masses. Laryngoscope. 2001;111:1989–92.
Schmidt RL, Hall BJ, Wilson AR, Layfield LJ. A systematic review and meta-analysis of the diagnostic accuracy of fine-needle aspiration cytology for parotid gland lesions. Am J Clin Pathol. 2011;136:45–59.
Spiro JD, Spiro RH. Cancer of the parotid gland: role of 7th nerve preservation. World J Surg. 2003;27:863–7.
Magnano M, Fernando Gervasio C, Cravero L, et al. Treatment of malignant neoplasms of the parotid gland. Otolaryngol Head Neck Surg. 1999;121:627–32.
Zbären P, Schüpbach J, Nuyens M, Stauffer E. Elective neck dissection versus observation in primary parotid carcinoma. Otolaryngol Head Neck Surg. 2005;132:387–91.
Armstrong JG, Harrison LB, Thaler HT, et al. The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer. 1992;69(3):615–619.
Klussmann J, Ponert T, Mueller R, Dienes H, Guntinas-Lichius O. Patterns of lymph node spread and its influence on outcome in resectable parotid cancer. EJSO Eur J Surg Oncol. 2008;34:932–7.
Lim CM, Gilbert M, Johnson JT, Kim S. Is level V neck dissection necessary in primary parotid cancer? Laryngoscope. 2015;125:118–21.
Lau VH, Aouad R, Farwell DG, Donald PJ, Chen AM. Patterns of nodal involvement for clinically N0 salivary gland carcinoma: refining the role of elective neck irradiation. Head Neck. 2014;36:1435–9.
Ali S, Palmer FL, DiLorenzo M, Shah JP, Patel SG, Ganly I. Treatment of the neck in carcinoma of the parotid gland. Ann Surg Oncol. 2014;21:3042–8.
Stodulski D, Mikaszewski B, Majewska H, Wiśniewski P, Stankiewicz C. Probability and pattern of occult cervical lymph node metastases in primary parotid carcinoma. Eur Arch Oto-Rhino-Laryngol. 2017;274:1659–64.
Weiss MH, Harrison LB, Isaacs RS. Use of decision analysis in planning a management strategy for the stage NO neck. Arch Otolaryngol Head Neck Surg. 1994;120:699–702.
Wang YL, Li DS, Gan HL, et al. Predictive index for lymph node management of major salivary gland cancer. Laryngoscope. 2012;122:1497–506.
Pan W, Ba K, Niu X, Liu F, Fang Q. Sentinel lymph node biopsy in cN0 neck management of parotid cancer. Sci Rep. 2019;9:8339.
Chen AM, Garcia J, Lee NY, Bucci MK, Eisele DW. Patterns of nodal relapse after surgery and postoperative radiation therapy for carcinomas of the major and minor salivary glands: what is the role of elective neck irradiation? Int J Radiat Oncol Biol Phys. 2007;67:988–94.
Ang KK, Trotti A, Brown BW, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51:571–8.
Cho J-K, Lim B-W, Kim E-H, et al. Low-grade salivary gland cancers: treatment outcomes, extent of surgery, and indications for postoperative adjuvant radiation therapy. Ann Surg Oncol. 2016;23:4368–75.
Kawata R, Yoshimura K, Lee K, Araki M, Takenaka H, Tsuji M. Basal cell adenoma of the parotid gland: a clinicopathological study of nine cases: basal cell adenoma versus pleomorphic adenoma and Warthin’s tumor. Eur Arch Oto-Rhino-Laryngol. 2010;267:779–83.
Stenner M, Molls C, Luers JC, Beutner D, Klussmann JP, Huettenbrink K-B. Occurrence of lymph node metastasis in early-stage parotid gland cancer. Eur Arch Oto-Rhino-Laryngol. 2012;269:643–8.
Shinomiya H, Otsuki N, Yamashita D, Nibu K-i. Patterns of lymph node metastasis of parotid cancer. Auris Nasus Larynx. 2016;43:446–50.
Jinnin T, Kawata R, Higashino M, Nishikawa S, Terada T, Haginomori S-I. Patterns of lymph node metastasis and the management of neck dissection for parotid carcinomas: a single-institute experience. Int J Clin Oncol. 2019;24:624–31.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
There are no conflicts of interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Warshavsky, A., Rosen, R., Muhanna, N. et al. Rate of Occult Neck Nodal Metastasis in Parotid Cancer: A Meta-Analysis. Ann Surg Oncol 28, 3664–3671 (2021). https://doi.org/10.1245/s10434-020-09331-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-020-09331-7